Monarch Medical Technologies Announces New Insulin-on-Board Adjustment for Subcutaneous Insulin Dosing

19

CHARLOTTE, N.C.–(BUSINESS WIRE)–Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an additional feature of Monarch EndoTool SubQ, an insulin-on-board (IOB) algorithm. Monarch’s precision electronic glycemic management system, EndoTool SubQ, recommends a personalized therapy regime for basal-bolus-correction subcutaneous insulin. The company, which first…

 

http://www.businesswire.com/news/home/20190607005067/en/Monarch-Medical-Technologies-Announces-New-Insulin-on-Board-Adjustment